EchoSolv AS vs PMcardio
AI Verdict
Choose EchoSolv AS if…
Choose EchoSolv AS if your primary focus is the accurate and efficient identification of patients at risk for severe aortic stenosis based on echocardiogram analysis. This tool is ideal for cardiology departments seeking a second-reader support system to prioritize studies for closer review and integrate seamlessly into existing PACS workflows without requiring EMR integration.
View EchoSolv AS →Choose PMcardio if…
Choose PMcardio if you require rapid and comprehensive AI-powered interpretation of ECGs for a wide range of over 50 cardiac conditions, including STEMI/OMI and reduced LVEF. This platform is best suited for clinicians in emergency medicine, internal medicine, or cardiology who need instant, expert-level ECG analysis at the point of care, accessible via mobile app, web, or integrated with EHR/CVIS systems.
View PMcardio →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoSolv AS | PMcardio |
|---|---|---|
| Pricing | Unknown | Freemium |
| Deployment | Cloud-based | Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems |
| FDA Status | 1 AI-estimated | Pending AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
PMcardioPMcardio offers a mobile app and web platform, allowing clinicians to scan ECGs with a smartphone for instant analysis, which suggests a highly accessible and user-friendly experience at the point of care. EchoSolv AS, while designed to fit existing workflows and integrating with PACS, is cloud-based and analyzes numerical measurements, which may imply a less direct or immediate interaction for the end-user compared to a mobile app.
Clinical Value
PMcardioPMcardio detects over 50 cardiac conditions from ECGs, including STEMI/OMI and reduced LVEF, and has been validated in more than 25 clinical studies, demonstrating broad diagnostic utility and improved detection sensitivity for critical conditions. EchoSolv AS focuses specifically on identifying patients at risk for severe aortic stenosis with high accuracy, and while FDA-cleared and clinically validated, its scope is narrower.
Pricing & Value
PMcardioPMcardio offers a freemium model with a free plan for 5 ECG analyses per month, making it accessible for individual clinicians to try and use for basic needs, with a 'Pro Plan' for unlimited use and advanced features. EchoSolv AS operates on a subscription-based model, with reimbursement codes being identified, but does not publicly offer a free tier for individual use.
Enterprise Readiness
PMcardioPMcardio offers enterprise integrations with EHR/CVIS and EMS systems, with features like centralized access, configurable user permissions, and robust security protocols (SOC 2 Type II, ISO 27001, GDPR, HIPAA). EchoSolv AS is cloud-based, HIPAA compliant, and integrates with PACS, but the available information doesn't detail the same breadth of enterprise-specific features and integrations as PMcardio.
Innovation
PMcardioPMcardio demonstrates strong innovation with its 'ECGxplainu2122' feature, providing visual AI explainability with heatmaps to show the rationale behind its diagnoses, and its ability to detect over 50 cardiac conditions from ECGs. EchoSolv AS offers AI-powered clinical decision support for severe aortic stenosis, utilizing measurement-based AI that doesn't rely on LVOT measurements, which is innovative for its specific focus.
Support & Docs
PMcardioPMcardio provides a Help Center with user-friendly tutorials, manuals, and FAQs, along with regulatory and security documentation, indicating comprehensive support resources. EchoSolv AS mentions product labeling for indications, cautions, warnings, and contraindications, but the publicly available information does not detail the same breadth of user-focused support documentation as PMcardio.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoSolv AS | PMcardio |
|---|---|---|
| Tool Name | EchoSolv AS | PMcardio |
| Company | Echo IQ | Powerful Medical |
| Description | EchoSolv AS is an FDA-cleared, AI-powered clinical decision support platform by Echo IQ that analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency, integrating into existing workflows. | PMcardio is a CE-certified AI platform that interprets ECGs to assess over 50 cardiac conditions rapidly and accurately. Clinically validated in more than 25 studies and trusted by over 100,000 clinicians, it delivers rapid, expert-level interpretations, empowering various healthcare professionals to act with confidence at the point of care. |
| Key Functionality | AI-powered clinical decision support for severe aortic stenosis probability, consistent severe AS probability and guideline check from measurements, second reader support to help prioritize studies for closer review. | Instant AI-powered ECG interpretations, detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders), visual AI Explainability with heatmaps. |
| Specialties | Cardiology, Cardiothoracic Surgery | Cardiology, Emergency Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring EchoSolv AS and PMcardio.